Endo Health Solutions (ENDP) announced after the bell Wednesday that it is exploring strategic alternatives for its HealthTronics business and branded pharmaceutical discovery platform. The company expects to report full year 2013 adjusted EPS of $4.10 to $4.40. The consensus estimate is for EPS of $4.27. The stock is now up 0.81 on 88K shares.
Endo Health Solutions dipped in early trade Wednesday, but settled into a range for the majority of the session. Shares finished down by 0.50 at $35.96.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.